key: cord-1026351-yigdvc1q
authors: Wilson, N.; Schwehm, M.; Verrall, A. J.; Parry, M.; Baker, M. G.; Eichner, M.
title: Detecting the Emergent or Re-Emergent COVID-19 Pandemic in a Country: Modelling Study of Combined Primary Care and Hospital Surveillance
date: 2020-05-19
journal: nan
DOI: 10.1101/2020.05.13.20100743
sha: 7bbbf25a5de3ee2233028aa5dab01da96a99828e
doc_id: 1026351
cord_uid: yigdvc1q

Aims: We aimed to determine the effectiveness of surveillance using testing for SARS-CoV-2 to identify an outbreak arising from a single case of border control failure at a country level. Methods: A stochastic version of the SEIR model CovidSIM v1.1 designed specifically for COVID-19 was utilised. It was seeded with New Zealand (NZ) population data and relevant parameters sourced from the NZ and international literature. Results: For what we regard as the most plausible scenario with an effective reproduction number of 2.0, the results suggest that 95% of outbreaks from a single imported case would be detected in the period up to day 33 after introduction. At the time point of detection, there would be a median number of 6 infected cases in the community (95%UI: 1-68). To achieve this level of detection, an on-going programme of 7,800 tests per million people per week for the NZ population would be required. The vast majority of this testing (96%) would be of symptomatic cases in primary care settings and the rest in hospitals. Despite the large number of tests required, there are plausible strategies to enhance testing yield and cost-effectiveness eg, (i) adjusting the eligibility criteria via symptom profiles; (ii) and pooling of test samples. Conclusions: This model-based analysis suggests that a surveillance system with a very high level of routine testing is probably required to detect an emerging or re-emerging SARS-CoV-2 outbreak within one month of a border control failure in a nation.

One of the challenges with a new pandemic such as COVID-19, is how best to undertake surveillance. Good quality surveillance is needed to maximise rapid disease control eg, with case isolation and contact tracing to identify further cases and to quarantine contacts. This capacity is particularly critical for nations that decide to contain spread at an early stage and even eliminate transmission entirely (eg, as New Zealand has planned [1] and Australia has as a potential option [2] ). In particular it may be relevant to the following groupings of island jurisdictions (as per WHO data on 5 May 2020 [3] ):

 Those jurisdictions which have avoided any COVID-19 cases to date (eg, via border controls), but which are still at risk if border controls fail. These mainly include island jurisdictions in the Pacific Ocean (eg, American Samoa, Cook Islands, Federated States of 2 Micronesia, Kiribati, Marshall Islands, Nauru, Niue, Palau, Samoa, Solomon Islands, Tokelau, Tonga, Tuvalu, Vanuatu, and Wallis and Futuna).  Those jurisdictions which have only experienced sporadic cases and may have successfully contained spread. These are mainly Caribbean islands (eg, Trinidad and Tobago) but also include some islands in the Pacific (eg, Fiji).  Those jurisdictions which have had larger outbreaks of COVID-19, but have instituted tight border controls and have declining numbers of new cases. These settings may therefore be on track towards eliminating the virus (eg, Australia, New Zealand and Taiwan).

A recent Australian study [4] , suggested that timely detection and management of community transmission of COVID-19 is feasible. This modelling study concluded that "testing for infection in primary care patients presenting with cough and fever is an efficient, effective and feasible strategy for the detection and elimination of transmission chains". For example, when testing 9000 people per week (per million population), the authors estimated that no cases of COVID-19 would be missed in some circumstances. This type of surveillance could therefore be relevant to identifying emergent or re-emergent SARS-CoV-2, the pandemic virus causing COVID-19.

Given this background, we aimed to determine the effectiveness of surveillance using testing for the SARS-CoV-2 virus to identify an outbreak arising from a single case of border control failure in a nation without it.

To [6] , but in the Appendix we provide updated parameters and differential equations for version 1.1. The stochastic model was built in Pascal and 100,000 simulations were run for each set of parameter values.

The parameters were based on available publications and best estimates used in the published modelling work on COVID-19 (as known to us on 6 May 2020). Key components were: a single undetected infected case arriving in New Zealand via a border control failure, 80% of infected COVID-19 cases being symptomatic, 39.5% of cases seeking a medical consultation in primary care settings, and 4% of symptomatic cases being hospitalised (see Table A1 in the Appendix for further details). We assumed that the initial undetected case could be at any stage of infectionto cover both failures of managing quarantine at the border, but also failures around the management of nonquarantined workers such as air-crew and ship-crew. Scenarios considered different levels of transmission with the effective reproduction number (Re) of SARS-CoV-2 to be 1.5, 2.0, 2.5 and 3.0 (Table A1) . Other scenarios considered the impact of 75% of symptomatic people seeking a medical consultation (eg, as the result of a potential media campaign); and another considered a possible school outbreak (eg, a border control failure involving a teacher or student returning from overseas). The assumptions for the latter involved: Re = 2.0, only 5% of symptomatic cases seek medical consultation, and only 0.5% being hospitalised.

For the detection of COVID-19 cases, we assume testing of 95% of cases of symptomatic cases of respiratory illness seeking medical attention in primary care and of hospitalised cases of respiratory illness. For parameterising the size of these two groups, we used official statistics and results from 3 the Flutracking surveillance system used in New Zealand (Table A1 ). The sensitivity of the PCR diagnostic test (at 89%) was based on a meta-analysis (Table A1) .

For what we regard as the most plausible scenario with an Re of 2.0 (ie, where people are practicing some level of reduced social contact because of the pandemic in other countries), the results suggest that 50% of outbreaks from a single imported case would be detected in the period up to day 13 and 95% in the period up to day 33 (Table 1, Figure 1 ). At the time of detection (to day 33), there was an estimated median number of 6 infected cases in the community (95% uncertainty interval [UI]: 1-68). Similarly, for this same period, we expected that 4.7 primary care consultations and 0.5 hospitalisations of COVID-19 patients will have occurred. To achieve this level of detection, an ongoing programme of 5,600 tests per day would be required, which is 7,800 tests per million people per week for the whole New Zealand population. This is one test per 128 individuals per week when combining the testing of the 39.5% seeking medical attention for cough and fever symptoms and the testing of those being hospitalised for respiratory conditions. The vast majority of this testing (96%) would however, be in primary care settings and the rest in hospitals.

For all scenarios, 95% of outbreaks were detected before five weeks after introduction. The highest value (32 days) was for the simulated school outbreak where medical consultations were assumed to be much less likely (due to symptoms in young people being typically milder). Increasing the extent by which symptomatic people seek medical consultations to the 75% level (up from that reported by Flutracking at 39.5%), would reduce the time to detection (eg, from 33 to 23 days for the Re = 2.0 scenario at the 95% probability level, Table 1 ). . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 19, 2020. . https://doi.org/10.1101/2020.05.13.20100743 doi: medRxiv preprint 47 (2-562) 4.9 0.5 * From the time of the border control failure to the mean day of outbreak detection. This is around 5,600 tests per day for primary care and hospital sectors combined for the first four listed scenarios. ** Includes those in the latent phase, prodromal phase, asymptomatic infections and symptomatic infections (but not recovered or deceased cases). *** The assumed characteristics for this school outbreak involved: Re = 2.0, only 5% of symptomatic cases seeking medical consultation, and only 0.5% being hospitalised. The level of testing was as per the first four listed scenarios.

This analysis indicates the challenges for a surveillance system designed to detect the emergence or re-emergence of SARS-CoV-2 transmission in a nation with border controls. A very high level of testing is typically required in primary care settings and hospitals to detect an outbreak arising from a single border control failure.

This testing level, at 7,800 per week per million population, is somewhat higher than the levels in NZ in early May 2020 (ie, the 7-day rolling average at this time was around 4,200 tests per day [7] , which is around 6000 people per week per million population, although this included some screening of asymptomatic people). Also achieving this high level of testing would require maintaining public support and participation with testing in an environment where border control failures might be considered to be rare events (though even a 14-day quarantine period for arriving travellers is likely to have a small failure rate [8] ).

Despite the high level of testing required for this type of surveillance system, there are potential ways that might improve the yield and cost-effectiveness of such testing:  Further refining eligibility criteria for testing in the primary care setting (eg, rather than just cough and fever). This could improve both the sensitivity and specificity of the surveillance system (eg, patients with self-reported olfactory and taste disorders had high specificity as a screening criterion in a Singapore study [9] ). While PCR tests typically have very high specificity, the test kits with the best characteristics could be evaluated for cost-effectiveness.  Pooling samples for PCR testing may preserve reagents and be more cost-effective [10] , but would need to be balanced against potential loss of sensitivity and associated diagnostic delays.

Furthermore, extremely comprehensive testing of all hospitalised cases with respiratory symptoms has some other advantages. It assists with appropriate diagnosis and management of COVID-19 cases when these are identified, but it also may protect against a hospital outbreak of COVID-19 which could endanger lives of inpatients and put many health workers into quarantine.

This is the first such modelling analysis for a country with an elimination goal for COVID-19. Nevertheless, this work could have been refined further by a focus on a narrower range of acute respiratory diseases (eg, excluding the category of hospital admissions for chronic lower respiratory diseases (ICD10 codes: J40-J47). But since hospital admissions for these often involve an acute aspect eg, acute bronchitis on top of chronic obstructive respiratory disease, we took the parsimonious approach of considering all respiratory diseases.

This analysis also did not explore other surveillance options such as routine active surveillance of specific groups (eg, air-crew, ship-crew and port workers), or the testing of town and city sewerage systems for the virus, as is being explored in several jurisdictions internationally [11] [12] . Yet these surveillance issues should also be considered by nations that aim to keep the COVID-19 pandemic out or eliminate it.

In conclusion, this model-based analysis suggests that a surveillance system with a very high level of routine testing is probably required to detect an emerging or re-emerging SARS-CoV-2 outbreak . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 19, 2020. . 6 within one month of a border control failure in a nation. But further work is required to improve on this type of analysis and to evaluate other potential surveillance system components.

Funding: Dr Schwehm is supported by the University of Tübingen and the IMAAC-NEXT Association. Professor Wilson is supported by the New Zealand Health Research Council and Ministry of Business Innovation and Employment (MBIE) funding of the BODE 3 Programme. However, these organisations had no role in the decision to perform this study, in its content, or the decision to publish.

The authors have no competing interests.

The stochastic simulations are based on the following differential equations: CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 19, 2020. 

Contact rate

The kind of epidemiologic events and the duration between two consecutive events are calculated using random numbers. The simulations start with a fully susceptible population in which one individual (index case) is infected. The infection stage of the index case is picked at random, taking into consideration the different lengths of the latent, prodromal, early and late infectious period. In each simulation, the sum of all the rates that change the current state of the system is calculated as is chosen, and the first transition in the order whose cumulative rate is larger than 2 r is performed. If, for example, the event is an infection, one individual is removed from the group of susceptible individuals and added to the group of latent individuals of stage 1. New rates are calculated after each step, and the procedure is repeated. A more detailed description of the transformation of differential equation models to stochastic models can be found in Gillespie (1976) [13] .

Parameters N Population size . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 19, 2020. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 19, 2020. . https://doi.org/10.1101/2020.05.13.20100743 doi: medRxiv preprint [14] ). Infections that lead to sickness 80% We used the same proportion (80%) of symptomatic cases as per a Chinese study [15] , and as per an Australian modelling study. [4] This value is higher than the 57% value found in an Icelandic study [16] but this study did not involve long-term follow-up of the asymptomatic cases (ie, some of the asymptomatic cases might subsequently have developed symptoms). But it is also lower than that found in another Chinese study (at 94% symptomatic) [17] . Sick people who seek medical attention in primary care 39.5% (75% in scenario analyses)

We used the result from the NZ Flutracking surveillance system for people with "fever and cough" in the weekly surveys who report seeking medical attention for these symptoms [18] . This is very similar to international estimates for people with influenza who seeking medical attention at 40% eg, as used in other modelling [5] . In scenario analyses we raised this to 75% on the assumption that a media campaign could encourage attendance for relatively mild respiratory symptoms. Sick people need hospitalisation

At the time of writing on 3 May 2020, there were 8 people hospitalised in NZ with COVID-19 (out of a total of 201 actively infected cases, ie, 4.0% [19] ). Of note is that modellers in the United Kingdom (UK) have used 4.4% (of all infected cases) [20] , and for modelling in the United States 3%, 5% and 12% have been proposed [21] . The length of hospitalisation was assumed to be 10 days which is similar to other modelling work eg, 10 There is uncertainty around this value but we used the same estimate as in recent UK modelling [20] . This has biological plausibility as while there is similarity in viral loads between asymptomatic and symptomatic COVID-19 patients [24] , it would be expected that those who are fully symptomatic (with a cough etc.) would be more likely to transmit infection. Of note is an estimate from the Diamond Princess cruise ship outbreak, that 17.9% of COVID-19 infections were from asymptomatic individuals (95% credible interval 15.5-20.2%) [25] . But it is unclear how generalisable this finding is given the crowded cruise ship conditions and the typically elderly nature of the passengers. Latency period 4 days We used an average duration of 4 days as per Read et al [26] , with a standard deviation (SD) of 25% (1 day) (calculated using 16 stages; Erlang distribution). This is similar to the estimate in a Chinese study which reported a median latent period of 3.69 days [27] . Prodromal period 1 day

There is as yet insufficient data on this for COVID-19, so we used an assumed value for influenza (SD = 25%; 0.25 days), Erlang distribution). Symptomatic period 10 days (split into 2 periods of 5 days each)

The WHO-China Joint Mission report stated that "the median time from onset to clinical recovery for mild cases is approximately 2 weeks and is 3-6 weeks for patients with severe or critical disease" [28] . But given that mild cases may have been missed in this particular assessment, we used a . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 19, 2020. In the first five days of symptoms, cases were considered to be fully contagious. In the second five-day period, this was assumed to be at 50%. The latter figure is highly uncertain, but is broadly consistent with one study on changing viral load [29] . Data from the NZ arm of the Flutracking surveillance system was used. This indicates that approximately 3% of respondents in the period from April to October report "fever and cough" in the weekly surveys [18] . Of these 39.5% report seeking medical attention for their symptoms. However, we assumed a lower annual rate of 2% to account for the period outside of the influenza season (eg, Flutracking reporting is closer to 1% for weekly "fever and cough" at the start of May when the surveillance system begins for the year). In the NZ population of 5 million this would suggest 14,300 new cases developing "cough and fever" per day of whom 5640 would be expected to seek medical attention. Coverage in patients with respiratory symptoms who seek medical attention in primary care

These coverage values were further adjusted for the test sensitivity of 89% (see below). With 95% coverage and 89% test sensitivity, 84.55% of cases would be detected.

Coverage in hospitalised patients with respiratory symptoms 95% coverage As above.

A meta-analysis has reported this as 89% (95%CI: 81 to 94%) [31] . This sensitivity is not ideal as while infection can be in the lungs, the sampling is from the nasopharynx, which may contain lower levels of virus at some stages of infection. Specificity is close to 100% for the PCR test.

Delay from symptom onset until a test has been performed and the result has become available 5 days plus 1 day for the testing delay There is a delay between symptom onset and the performance of the test for SARS-CoV-2. For the first part of the delay we considered a study in Beijing, China, which reported the interval time from between illness onset and seeing a doctor was 4.5 days [32] . Another Chinese study of 710 patients with pneumonia [33] reported that those dying had a median duration from onset of symptoms to radiological confirmation of pneumonia of 5 (IQR: 3-7) days. For the testing delay we noted that the aim in NZ is to obtain the result of the tests in under 24-hours regardless of the primary care or hospital setting. But this may not always be the case for rural and small town settings. In our simulations, test results were available on average 5.94 days after symptom onset (SD: 1.36 days).

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted May 19, 2020. .

New Zealand's elimination strategy for the COVID-19 pandemic and what is required to make it work

COVID-19 Roadmap to Recovery: A Report for the Nation. The Group of Eight Ltd

World Health Organization. Coronavirus disease 2019 (COVID-19) Situation Report -106

Exit strategies: optimising feasible surveillance for detection, elimination and ongoing prevention of COVID-19 community transmission

Modelling the potential health impact of the COVID-19 pandemic on a hypothetical European country

Potential health impacts from the COVID-19 pandemic for New Zealand if eradication fails: Report to the NZ Ministry of Health

Lab testing and capacity. New Zealand Ministry of Health

The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: Estimation and application

The role of selfreported olfactory and gustatory dysfunction as a screening criterion for suspected COVID-19

Sample pooling as a strategy to detect community transmission of SARS-CoV-2

How sewage could reveal true scale of coronavirus outbreak

Coronavirus found in Paris sewage points to early warning system

A general method for numerically simulating the stochastic time evolution of coupled chemical reactions

Statistics New Zealand

Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study

Spread of SARS-CoV-2 in the Icelandic Population

Modes of contact and risk of transmission in COVID-19 among close contacts

Ministry of Health. COVID-19 -current cases

Impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand

World Health Organization. Coronavirus disease 2019 (COVID-19) Situation Report -46

The reproductive number of COVID-19 is higher compared to SARS coronavirus

SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients

Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship

Novel coronavirus 2019-nCoV: early estimation of epidemiological parameters and epidemic predictions

Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV2)

WHO-China Joint Mission. Report of the WHO-China Joint Mission on Coronavirus Disease

Virological assessment of hospitalized patients with COVID-2019. Nature. 2020. 30. Ministry of Health. Publicly funded hospital discharges -1

Diagnostic Performance of CT and Reverse Transcriptase-Polymerase Chain Reaction for Coronavirus Disease 2019: A Meta-Analysis

Characteristics of COVID-19 infection in Beijing

Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study